Boundless Bio, Common Stock Market Value
| BOLD Stock | USD 10.66 0.65 6.49% |
| Symbol | Boundless |
Boundless Bio, Common Price To Book Ratio
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.33) | Return On Equity (0.53) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Boundless Bio, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio,.
| 03/24/2024 |
| 04/23/2024 |
If you would invest 0.00 in Boundless Bio, on March 24, 2024 and sell it all today you would earn a total of 0.00 from holding Boundless Bio, Common or generate 0.0% return on investment in Boundless Bio, over 30 days. Boundless Bio, is related to or competes with Equillium, Kineta, YS Biopharma, DiaMedica Therapeutics, Valneva SE, Vivani Medical, and Vaxxinity. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.56) | |||
| Maximum Drawdown | 17.62 | |||
| Value At Risk | (10.71) | |||
| Potential Upside | 6.91 |
Boundless Bio, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio,'s standard deviation. In reality, there are many statistical measures that can use Boundless Bio, historical prices to predict the future Boundless Bio,'s volatility.| Risk Adjusted Performance | (0.32) | |||
| Jensen Alpha | (2.03) | |||
| Total Risk Alpha | (2.48) | |||
| Treynor Ratio | (5.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Boundless Bio,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Boundless Bio, Common Backtested Returns
Boundless Bio, Common secures Sharpe Ratio (or Efficiency) of -0.52, which signifies that the company had a -0.52% return per unit of risk over the last 3 months. Boundless Bio, Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boundless Bio,'s Standard Deviation of 3.72, mean deviation of 2.6, and Risk Adjusted Performance of (0.32) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boundless Bio,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Boundless Bio, is expected to be smaller as well. Boundless Bio, Common has an expected return of -1.88%. Please make sure to confirm Boundless Bio, Common accumulation distribution, and the relationship between the potential upside and day median price , to decide if Boundless Bio, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.92 |
Excellent predictability
Boundless Bio, Common has excellent predictability. Overlapping area represents the amount of predictability between Boundless Bio, time series from 24th of March 2024 to 8th of April 2024 and 8th of April 2024 to 23rd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio, Common price movement. The serial correlation of 0.92 indicates that approximately 92.0% of current Boundless Bio, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.92 | |
| Spearman Rank Test | 0.93 | |
| Residual Average | 0.0 | |
| Price Variance | 0.39 |
Boundless Bio, Common lagged returns against current returns
Autocorrelation, which is Boundless Bio, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Boundless Bio,'s stock expected returns. We can calculate the autocorrelation of Boundless Bio, returns to help us make a trade decision. For example, suppose you find that Boundless Bio, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Boundless Bio, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Boundless Bio, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Boundless Bio, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Boundless Bio, stock over time.
Current vs Lagged Prices |
| Timeline |
Boundless Bio, Lagged Returns
When evaluating Boundless Bio,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Boundless Bio, stock have on its future price. Boundless Bio, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Boundless Bio, autocorrelation shows the relationship between Boundless Bio, stock current value and its past values and can show if there is a momentum factor associated with investing in Boundless Bio, Common.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Boundless Bio, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Boundless Bio,'s short interest history, or implied volatility extrapolated from Boundless Bio, options trading.
Pair Trading with Boundless Bio,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boundless Bio, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will appreciate offsetting losses from the drop in the long position's value.Moving together with Boundless Stock
| 0.62 | YS | YS Biopharma | PairCorr |
Moving against Boundless Stock
| 0.51 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.49 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.48 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | VERV | Verve Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.46 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Boundless Bio, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boundless Bio, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boundless Bio, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boundless Bio, Common to buy it.
The correlation of Boundless Bio, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boundless Bio, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boundless Bio, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boundless Bio, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Boundless Bio, Correlation, Boundless Bio, Volatility and Boundless Bio, Alpha and Beta module to complement your research on Boundless Bio,. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Boundless Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.